XCUR Stock Analysis: Buy, Sell, or Hold?
XCUR - Exicure, Inc. Common Stock
$2.96
-0.20 (-6.33%)
▼
5d:
-0.34%
30d:
-12.94%
90d:
-25.81%
BUY
MODERATE Confidence
Analysis Updated: Jun 4, 2026 12:00 AM ET
Earnings: Jun 26, 2026
20d
Get Alerted When XCUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XCUR shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: XCUR shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: XCUR is currently trading at $2.96, which is considered slightly low relative to its 30-day fair value range of $2.91 to $3.38.
Technical Outlook: Technically, XCUR is in a strong downtrend. Immediate support is located at $2.63, while resistance sits at $3.45. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XCUR is in a strong downtrend. Immediate support is located at $2.63, while resistance sits at $3.45. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.91 -
$3.38
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.3%)
- BEARISH: Trading 32.4% above Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$2.91 -
$3.38
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.63
Resistance Level
$3.45
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Wall Street Target
$2.00
(-32.4%)
Revenue Growth (YoY)
928.0%
Share & Embed Analysis
Last updated: June 05, 2026 9:30 AM ET
Data refreshes hourly during market hours. Next update: 10:30 AM
Data refreshes hourly during market hours. Next update: 10:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XCUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Sangsangin Investment & …
SELL
433332 shares
2025-12-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 58 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 61 BUY |